THE COST EFFECTIVENESS OF GOLIMUMAB AS AN ADD-ON TO CONVENTIONAL CARE COMPARED TO CC FOR THE TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN SCOTLAND

May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1153
https://www.valueinhealthjournal.com/article/S1098-3015(16)01221-3/fulltext
Section Title : Muscular-Skeletal Disorders - Cost Studies
Section Order : 829
First Page : A234
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01221-3&doi=10.1016/j.jval.2016.03.1153
HEOR Topics :
Tags :
Regions :